Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

Clinical trial NCT03760575 · RECRUITING

Trial details

NCT number: NCT03760575
Sponsor: Abramson Cancer Center at Penn Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Mesotheliomas Pleural

Start date: 2023-01-10
Primary completion: 2027-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.